{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:23:26Z","timestamp":1792794206699,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Penn Center for AIDS Research","id":[{"id":"https:\/\/ror.org\/047939x15","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI 045008"],"award-info":[{"award-number":["P30 AI 045008"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,18]]},"DOI":"10.1093\/cid\/ciy515","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T07:42:42Z","timestamp":1529307762000},"page":"393-401","source":"Crossref","is-referenced-by-count":75,"title":["Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus\u2013associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial"],"prefix":"10.1093","volume":"68","author":[{"given":"Joseph N","family":"Jarvis","sequence":"first","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership, Gaborone"},{"name":"Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia"},{"name":"Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom"},{"name":"University of Botswana, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tshepo B","family":"Leeme","sequence":"additional","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mooketsi","family":"Molefi","sequence":"additional","affiliation":[{"name":"University of Botswana, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awilly A","family":"Chofle","sequence":"additional","affiliation":[{"name":"National Institute of Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Bidwell","sequence":"additional","affiliation":[{"name":"National Institute of Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katlego","family":"Tsholo","sequence":"additional","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nametso","family":"Tlhako","sequence":"additional","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Mawoko","sequence":"additional","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju K K","family":"Patel","sequence":"additional","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Tenforde","sequence":"additional","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Muthoga","sequence":"additional","affiliation":[{"name":"Botswana\u2013University of Pennsylvania Partnership, Gaborone"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P","family":"Bisson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Kidola","sequence":"additional","affiliation":[{"name":"National Institute of Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Changalucha","sequence":"additional","affiliation":[{"name":"National Institute of Medical Research, Mwanza, Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbar","family":"Jaffar","sequence":"additional","affiliation":[{"name":"Department of International Public Health, Liverpool School of Tropical Medicine, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hope","sequence":"additional","affiliation":[{"name":"Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u0301le F","family":"Molloy","sequence":"additional","affiliation":[{"name":"Centre for Global Health, Institute for Infection and Immunity, St George\u2019s University of London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S","family":"Harrison","sequence":"additional","affiliation":[{"name":"Centre for Global Health, Institute for Infection and Immunity, St George\u2019s University of London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"key\n\t\t\t\t2019011723583341900_CIT0001","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0002","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","volume":"22","author":"Lawn","year":"2008","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0003","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2458-9-290","article-title":"Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda","volume":"9","author":"Amuron","year":"2009","journal-title":"BMC Public Health"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0004","doi-asserted-by":"crossref","first-page":"e28691","DOI":"10.1371\/journal.pone.0028691","article-title":"Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis","volume":"6","author":"Gupta","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0006","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0007","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0008","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0009","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0010","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0011","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/AAC.01698-15","article-title":"Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis","volume":"59","author":"Bicanic","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0012","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda","volume":"47","author":"Longley","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0013","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0b013e328354b419","article-title":"A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis","volume":"26","author":"Jackson","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0014","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/653606","article-title":"Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety","volume":"51","author":"Hamill","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2011.00944_1.x","article-title":"British HIV Association and British infection association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011","volume":"12","author":"Nelson","year":"2011","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00090-17","article-title":"Experimental models of short courses of liposomal amphotericin B for induction therapy for cryptococcal meningitis","volume":"61","author":"Lestner","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0018","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/jac\/dkl141","article-title":"Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion","volume":"57","author":"Vogelsinger","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0019","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/infdis\/jit164","article-title":"Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients","volume":"208","author":"O\u2019Connor","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0020","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1128\/AAC.01448-08","article-title":"Pharmacokinetics and buccal mucosal concentrations of a 15 milligram per kilogram of body weight total dose of liposomal amphotericin B administered as a single dose (15 mg\/kg), weekly dose (7.5 mg\/kg), or daily dose (1 mg\/kg) in peripheral stem cell transplant patients","volume":"53","author":"Gubbins","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbmt.2005.10.010","article-title":"High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study","volume":"12","author":"Mehta","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0022","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0023","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0024","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0025","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0026","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13063-015-0799-6","article-title":"Ambition-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial","volume":"16","author":"Molefi","year":"2015","journal-title":"Trials"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0027","volume-title":"Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, version 2.1","author":"National Institute of Allergy and Infectious Diseases, Division of AIDS","year":"2017"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0028","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.10.014","article-title":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","volume":"64","author":"Muzoora","year":"2012","journal-title":"J Infect"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0029","first-page":"e00725","article-title":"Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days","volume":"5","author":"Livermore","year":"2013","journal-title":"MBio"},{"key":"key\n\t\t\t\t2019011723583341900_CIT0030","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa","volume":"378","author":"Molloy","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/3\/393\/27512670\/ciy515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T11:44:13Z","timestamp":1571485453000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/3\/393\/5045212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,6,26]]},"published-print":{"date-parts":[[2019,1,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy515","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,1]]},"published":{"date-parts":[[2018,6,26]]}}}